AFYX Therapeutics is a clinical stage biopharmaceutical company
AFYX Therapeutics has raised €11M across 1 funding round from 1 investor, most recently a round in Jul 2019. Based in Copenhagen, Denmark; founded 2013; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2019-07-01 | Other | €11M |
| Sofinnova Partners |
| View deal → |
